These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17520665)

  • 1. Nanogel-based delivery system enhances PGE2 effects on bone formation.
    Kato N; Hasegawa U; Morimoto N; Saita Y; Nakashima K; Ezura Y; Kurosawa H; Akiyoshi K; Noda M
    J Cell Biochem; 2007 Aug; 101(5):1063-70. PubMed ID: 17520665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.
    Hayashi C; Hasegawa U; Saita Y; Hemmi H; Hayata T; Nakashima K; Ezura Y; Amagasa T; Akiyoshi K; Noda M
    J Cell Physiol; 2009 Jul; 220(1):1-7. PubMed ID: 19301257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss.
    Alles N; Soysa NS; Hussain MD; Tomomatsu N; Saito H; Baron R; Morimoto N; Aoki K; Akiyoshi K; Ohya K
    Eur J Pharm Sci; 2009 May; 37(2):83-8. PubMed ID: 19429414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of a novel polysaccharide nanogel cross-linking membrane for guided bone regeneration (GBR).
    Miyahara T; Nyan M; Shimoda A; Yamamoto Y; Kuroda S; Shiota M; Akiyoshi K; Kasugai S
    J Tissue Eng Regen Med; 2012 Aug; 6(8):666-72. PubMed ID: 22095663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single molecular mechanics of a cholesterol-bearing pullulan nanogel at the hydrophobic interfaces.
    Lee I; Akiyoshi K
    Biomaterials; 2004 Jul; 25(15):2911-8. PubMed ID: 14967522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones.
    Ikeda K; Okada T; Sawada S; Akiyoshi K; Matsuzaki K
    FEBS Lett; 2006 Dec; 580(28-29):6587-95. PubMed ID: 17125770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle.
    Morimoto N; Hirano S; Takahashi H; Loethen S; Thompson DH; Akiyoshi K
    Biomacromolecules; 2013 Jan; 14(1):56-63. PubMed ID: 23215439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy.
    Shimizu T; Kishida T; Hasegawa U; Ueda Y; Imanishi J; Yamagishi H; Akiyoshi K; Otsuji E; Mazda O
    Biochem Biophys Res Commun; 2008 Mar; 367(2):330-5. PubMed ID: 18158918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice.
    Kamolratanakul P; Hayata T; Ezura Y; Kawamata A; Hayashi C; Yamamoto Y; Hemmi H; Nagao M; Hanyu R; Notomi T; Nakamoto T; Amagasa T; Akiyoshi K; Noda M
    Arthritis Rheum; 2011 Apr; 63(4):1021-33. PubMed ID: 21190246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raspberry-like assembly of cross-linked nanogels for protein delivery.
    Hasegawa U; Sawada S; Shimizu T; Kishida T; Otsuji E; Mazda O; Akiyoshi K
    J Control Release; 2009 Dec; 140(3):312-7. PubMed ID: 19573568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
    Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering.
    Fujioka-Kobayashi M; Ota MS; Shimoda A; Nakahama K; Akiyoshi K; Miyamoto Y; Iseki S
    Biomaterials; 2012 Oct; 33(30):7613-20. PubMed ID: 22800537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Osteoconductive Ability of Two Types of Cholesterol-Bearing Pullulan (CHP) Nanogel-Hydrogels Impregnated with BMP-2 and RANKL-Binding Peptide: Bone Histomorphometric Study in a Murine Calvarial Defect Model.
    Xie C; Rashed F; Sasaki Y; Khan M; Qi J; Kubo Y; Matsumoto Y; Sawada S; Sasaki Y; Ono T; Ikeda T; Akiyoshi K; Aoki K
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual crosslinked hydrogel nanoparticles by nanogel bottom-up method for sustained-release delivery.
    Shimoda A; Sawada S; Kano A; Maruyama A; Moquin A; Winnik FM; Akiyoshi K
    Colloids Surf B Biointerfaces; 2012 Nov; 99():38-44. PubMed ID: 21996463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of refolding activities between nanogel artificial chaperone and GroEL systems.
    Asayama W; Sawada S; Taguchi H; Akiyoshi K
    Int J Biol Macromol; 2008 Apr; 42(3):241-6. PubMed ID: 18179818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels.
    Okamoto T; Saito T; Tabata Y; Uemoto S
    Biomaterials; 2011 Jul; 32(21):4925-35. PubMed ID: 21477856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular delivery of DNA and enzyme in active form using degradable carbohydrate-based nanogels.
    Ahmed M; Narain R
    Mol Pharm; 2012 Nov; 9(11):3160-70. PubMed ID: 22970989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and processing of nanogels as delivery systems for peptides and proteins.
    Arnfast L; Madsen CG; Jorgensen L; Baldursdottir S
    Ther Deliv; 2014 Jun; 5(6):691-708. PubMed ID: 25090282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraosseous infusion of prostaglandin E2 prevents disuse-induced bone loss in the tibia.
    Welch RD; Ashman RB; Baker KJ; Browne RH
    J Orthop Res; 1996 Mar; 14(2):303-10. PubMed ID: 8648510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.